You have 9 free searches left this month | for more free features.

Insulin Growth Factor I Resistance

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Serum Insulin-like Growth Factor Binding Protein-3 asPotential

Not yet recruiting
  • Colorectal Cancer
  • evaluation of diagnostic importance of insulin like growth factor binding protein3 in patient with recently diagnosed as Colorectal cancer
  • (no location specified)
May 6, 2023

Insulin Like Growth Factor-1 Against Oxidative Stress in

Not yet recruiting
  • Vitiligo
  • skin biopsy examined by ELISA technique
  • (no location specified)
Apr 13, 2023

Drug Effect Trial in Tanta (Cinacalcet)

Recruiting
  • Drug Effect
  • Tanta, Egypt
    Sara Mabrouk Mohamed Elghoul
Jun 29, 2023

UVB Phototherapy Burn, Insulin-like Growth Factor 1, Aging Trial in Fairborn (Insulin-Like Growth Factor 1, No Insulin-Lie

Recruiting
  • UVB Phototherapy Burn
  • +2 more
  • Insulin-Like Growth Factor 1
  • No Insulin-Lie Growth Factor 1
  • Fairborn, Ohio
    Wright State Physicians
Jan 9, 2023

Insulin Receptor Mutation, Partial Lipodystrophy Trial run by the National Institute of Diabetes and Digestive and Kidney

Not yet recruiting
  • Insulin Receptor Mutation
  • Partial Lipodystrophy
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 17, 2022

Sarcopenic Obesity in the Elderly

Completed
  • Sarcopenic Obesity
  • Diabetes
    • Orlando, Florida
      University of Central Florida
    Oct 17, 2023

    Myotonic Dystrophy Type 1 Trial in United States (rhIGF-I/rhIGFBP-3, )

    Completed
    • Myotonic Dystrophy Type 1
    • Orange, California
    • +11 more
    Dec 8, 2021

    Anorexia Nervosa Trial in Boston (RhIGF-1)

    Completed
    • Anorexia Nervosa
    • Boston, Massachusetts
      Massachusetts General Hospital
    Oct 22, 2021

    Acute Kidney Injury (Nontraumatic), Pneumoperitoneum Trial (IGF-1)

    Not yet recruiting
    • Acute Kidney Injury (Nontraumatic)
    • Pneumoperitoneum
    • IGF-1
    • (no location specified)
    Nov 8, 2022

    Sleep Disturbance, Postmenopausal Symptoms, Insulin Sensitivity Trial in Baton Rouge (Sleep Restriction, Habitual Sleep)

    Completed
    • Sleep Disturbance
    • +3 more
    • Sleep Restriction
    • Habitual Sleep
    • Baton Rouge, Louisiana
      Pennington Biomedical Research Center
    Nov 11, 2022

    Growth Hormone in EB

    Not yet recruiting
    • Epidermolysis Bullosa Dystrophica
    • growth hormone level and insulin like growth factor 1
    • (no location specified)
    May 24, 2022

    Cancer, Overweight and Obesity Trial (Aerobic Exercise)

    Not yet recruiting
    • Cancer
    • Overweight and Obesity
    • Aerobic Exercise
    • (no location specified)
    Dec 13, 2022

    Unraveling KAdcyla Resistance In Human Epidermal Growth Factor

    Completed
    • Advanced Breast Cancer
      • Sevilla, AndalucĂ­a, Spain
      • +9 more
      Jan 12, 2023

      Insulin Growth Factor I Deficiency, IGF1 Deficiency, Executive Function Disorder Trial in Seville (HIIT, HIIT+PA, CON)

      Recruiting
      • Insulin Growth Factor I Deficiency
      • +2 more
      • HIIT
      • +2 more
      • Seville, Spain
        Education Faculty
      Nov 30, 2022

      Insulin Resistance, Prediabetic State, Non-Alcoholic Fatty Liver Disease Trial in New York (drug, other, dietary supplement,

      Not yet recruiting
      • Insulin Resistance
      • +3 more
      • Insulin human
      • +11 more
      • New York, New York
        Columbia University Irving Medical Center
      Nov 6, 2023

      Adult Diabetic Macular Edema and Suboptimal Response to

      Not yet recruiting
      • Diabetic Macular Edema
        • (no location specified)
        Jul 31, 2023

        Relation Between Serum IGF-1 & BMI In Acne Vulgaris

        Not yet recruiting
        • Evaluation of Serum Level of Insulin Like Growth Factor 1
          • (no location specified)
          Aug 16, 2022

          Prostate Cancer Trial in Oxford (Xentuzumab)

          Recruiting
          • Prostate Cancer
          • Oxford, United Kingdom
            Churchill Hospital, Oxford University Hospitals
          Mar 14, 2022

          Disorder of Bone Density and Structure, Unspecified Trial in Boston (Recombinant human insulin like growth factor-1 (rhIGF-1))

          Completed
          • Disorder of Bone Density and Structure, Unspecified
          • Recombinant human insulin like growth factor-1 (rhIGF-1)
          • Boston, Massachusetts
            Massachusetts General Hospital
          Oct 22, 2021

          22q13 Deletion Syndrome, Phelan-McDermid Syndrome Trial in New York (Insulin-Like Growth Factor-1 (IGF-1), Normal saline)

          Completed
          • 22q13 Deletion Syndrome
          • Phelan-McDermid Syndrome
          • Insulin-Like Growth Factor-1 (IGF-1)
          • Normal saline
          • New York, New York
            Seaver Austin Center, Icahn School of Medicine at Mount Sinai
          Apr 18, 2022

          Insulin-Like Growth Factor I, Healthy Trial in London (Amino Acid Supplement, Placebo)

          Recruiting
          • Insulin-Like Growth Factor I
          • Healthy
          • Amino Acid Supplement
          • Placebo
          • London, Ontario, Canada
            KGK Science Inc.
          Jan 9, 2023

          Health Status of Children Born After Assisted Reproductive

          Recruiting
          • Children Born After Assisted Reproductive Technologies
          • +2 more
          • hemogram examination
          • Almaty, Kazakhstan
            Sevara ilmuratova
          Oct 17, 2023

          Tendinopathy, Patellar Ligament, Platelet-Rich Plasma Trial in Columbus (Platelet Rich Plasma, Platelet Rich Plasma plus IGF)

          Completed
          • Tendinopathy
          • +2 more
          • Platelet Rich Plasma
          • Platelet Rich Plasma plus IGF
          • Columbus, Ohio
            The Ohio State University Sports Medicine Center
          Aug 4, 2022

          Bladder Transitional Cell Carcinoma, Bladder Cancer, Fibroblast Growth Factor Receptor Trial (Infigratinib)

          Withdrawn
          • Bladder Transitional Cell Carcinoma
          • +2 more
          • (no location specified)
          Aug 8, 2022